In addition, increased expression of TFF3 is associated with poor prognosis of patients with various cancers, such as colorectal [27], gastric [14, 28, 29], hepatocellular [16], and mammary carcinomas [20, 30]. Here, TFF3 is linked to breast carcinoma.